Key statistics
On Wednesday, Ligand Pharmaceuticals Inc (LGNDZ:PKC) closed at 0.0022, 69.23% above the 52 week low of 0.0013 set on Nov 15, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0025 |
---|---|
High | 0.0025 |
Low | 0.0022 |
Bid | -- |
Offer | -- |
Previous close | 0.0022 |
Average volume | 4.93k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Oct 02 2024 17:34 BST.
More ▼
Press releases
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
- Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Ligand Reports Second Quarter 2024 Financial Results
- Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024